You are here

NeuroVive

FDA fast-tracks NeuroVive’s traumatic brain injury drug

Pharmaforum

Mon, 07/29/19 - 09:20 am

traumatic brain injury

NeuroVive's KL1333 Receives FDA Orphan Drug Designation for Treatment of Mitochondrial Diseases

CP Wire

Wed, 04/18/18 - 07:21 pm

Sanofi buys into NeuroVive's cardio drug in Korea

Fierce Biotech

Tue, 05/26/15 - 12:05 pm

NeuroVive pockets $3M on road to Taiwan IPO

Fierce Biotech

Thu, 02/12/15 - 09:57 am

NeuroVive and Sihuan Pharmaceutical to Develop and Commercialise CicloMulsion and NeuroSTAT for Cardio- and Neuroprotection in China

PharmaLive

Sat, 11/24/12 - 12:26 pm

Sihuan Pharmaceutical